Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Adenosine 5'-triphosphate disodium (ATP) is the primary energy carrier in all living cells, and its role in cellular metabolism is well established scientifically. As such, ATP has been investigated as a potential supplement to improve energy levels, particularly in contexts of fatigue or physical exertion. However, the evidence supporting oral ATP supplementation for the treatment of general fatigue or lack of energy in otherwise healthy individuals is limited and mixed.

Several small studies have examined ATP supplementation, often in the form of oral or intravenous ATP, for potential benefits in athletic performance or conditions associated with fatigue (e.g., chronic fatigue syndrome, cancer-related fatigue). Most oral ATP is rapidly degraded in the gastrointestinal tract, which limits its bioavailability. Some studies report mild improvements in exercise performance and reduced fatigue, but these findings are inconsistent and often not statistically significant. Intravenous ATP has shown some promise in reducing fatigue in specific populations, such as cancer patients, but this is not applicable to general consumer use.

Overall, while ATP is crucial for cellular energy production, the scientific evidence for its supplementation to treat or support general energy levels in healthy individuals is weak (rating: 2/5). Most benefits are either not clinically significant or are observed in very specific populations under medical supervision. More robust, large-scale clinical trials are needed to substantiate its efficacy for this indication.

More about adenosine 5-triphosphate disodium (ATP)
More about Energy (lack of)

Other ingredients used for Energy (lack of)

Other health conditions supported by adenosine 5-triphosphate disodium (ATP)

Products containing adenosine 5-triphosphate disodium (ATP)